Bin-Hui Yang
Impact in
-
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
-
- Protein Degradation and Inhibitors
- RNA modifications and cancer
- Ubiquitin and proteasome pathways
- Epigenetics and DNA Methylation
- Circular RNAs in diseases
- Extracellular vesicles in disease
Papers in
-
- Circular RNAs in diseases 2
- Ubiquitin and proteasome pathways 1
- Protein Degradation and Inhibitors 1
- Histone Deacetylase Inhibitors Research 1
- Bone Metabolism and Diseases 1
-
- MicroRNA in disease regulation 2
- Cancer-related molecular mechanisms research 2
- Co-authors
- Xiaochen Liu (1 shared paper)Qingjuan Chen (1 shared paper)Xu Dong Zhang (1 shared paper)Lirong Zhang (1 shared paper)Tao Liu (1 shared paper)Jinlong Zhao (3 shared papers)Yongkun Wei (1 shared paper)Jie Yang (1 shared paper)
In The Last Decade
Bin-Hui Yang
8 papers receiving 307 citations
Bin-Hui Yang's Hit Papers
Peers
Comparison fields: 5 of 55
- Cancer Research 122
- Molecular Biology 218
- Aging 4
- Geriatrics and Gerontology 4
- Oncology 26
Countries citing papers authored by Bin-Hui Yang
This map shows the geographic impact of Bin-Hui Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bin-Hui Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bin-Hui Yang more than expected).
Fields of papers citing papers by Bin-Hui Yang
This network shows the impact of papers produced by Bin-Hui Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bin-Hui Yang. The network helps show where Bin-Hui Yang may publish in the future.
Co-authors
The 25 scholars most cited alongside Bin-Hui Yang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Histone acetyltransferases CBP/p300 in tumorigenesis and CBP/p300 inhibitors as promising novel anticancer agents Hit paper breakdown → | 2022 | 167 |
| 2 | 2021 | 49 | |
| 3 | 2018 | 37 | |
| 4 | 2018 | 33 | |
| 5 | 2018 | 19 | |
| 6 | 2019 | 3 | |
| 7 | [One stage anterior debridement, bone fusion and internal fixation for the treatment of lumbosacral tuberculosis]. | 2013 | 1 |
| 8 | 2023 | 1 |
About Bin-Hui Yang
Bin-Hui Yang is a scholar working on Molecular Biology, Cancer Research, Process Chemistry and Technology, Biomedical Engineering and Infectious Diseases, having authored 8 papers that have together received 310 indexed citations. Recurring topics across this work include MicroRNA in disease regulation (2 papers), Cancer-related molecular mechanisms research (2 papers), Circular RNAs in diseases (2 papers), Ubiquitin and proteasome pathways (1 paper), Protein Degradation and Inhibitors (1 paper), Histone Deacetylase Inhibitors Research (1 paper), Bone Metabolism and Diseases (1 paper) and Carbon dioxide utilization in catalysis (1 paper). The work is most often cited by research in Cancer Research (122 citations), Molecular Biology (218 citations), Aging (4 citations), Geriatrics and Gerontology (4 citations) and Oncology (26 citations). Bin-Hui Yang has collaborated with scholars based in China and Australia. Frequent co-authors include Xiaochen Liu, Qingjuan Chen, Xu Dong Zhang, Lirong Zhang, Tao Liu, Jinlong Zhao, Yongkun Wei, Jie Yang, Yongcai Song and Bo Zhang. Their work appears in journals such as Biomedicine & Pharmacotherapy, Analytical Cellular Pathology, Journal of Solid State Chemistry, International Journal of Oncology and Aging.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.